Evidence map›Paper›PMID 42024842›Full record

ArticleJCO precision oncology2026

Comparative Analysis of

Shunit Armon, Sari Lieberman, Rachel Michaelson-Cohen, Ariela Tomer, Einat Koller-Volkow, Ephrat Levy-Lahad, Naama Srebnik

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in JCO precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shunit ArmonDepartment of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID 0000-0002-0216-9948
Sari LiebermanThe Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID 0000-0003-1671-6444
Rachel Michaelson-CohenDepartment of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel.
Ariela TomerThe Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem, Israel.
Einat Koller-VolkowDepartment of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel.
Ephrat Levy-LahadThe Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID 0000-0002-2637-1921
Naama SrebnikDepartment of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIsrael has pioneered population-wide screening (PS) for

methodsA cohort study conducted at

resultsWe identified 352 carriers: 202 PS and 150 OC. Sociodemographic characteristics were similar. PS carriers harbored more

conclusionIn a real-world setting, PS identified carriers with less FH and more

Indexed as

BRCA1 ProteinBRCA2 ProteinGenetic TestingOvarian NeoplasmsAdultCohort StudiesFemaleGenes, BRCA2Genetic CounselingHumansIsraelMiddle AgedBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Identifiers

PMID42024842
PMCPMC13132080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.